Longitudinal analysis of SARS-CoV-2 infection and vaccination in the LA-SPARTA cohort reveals increased risk of infection in vaccinated Hispanic participants

By sjmartinez • May 8, 2023

Jenkins MM, Phan Tran D, Flores EA, Kupferwasser D, Pickering H, Zheng Y, Gjertson DW, Ross TM, Schaenman JM, Miller LG, Yeaman MR, Reed EF. Longitudinal analysis of SARS-CoV-2 infection and vaccination in the LA-SPARTA cohort reveals increased risk of infection in vaccinated Hispanic participants. Front Immunol. 2023 Apr 19;14:1139915. doi: 10.3389/fimmu.2023.1139915. PMID: 37153624; PMCID: PMC10154521.

Tags: covid-19, Harbor UCLA, high-risk, infection, Infectious Diseases, Molecular Medicine, Publications, SARS-CoV-2, serological analysis, Vaccination

Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial

Giganti MJ, Chew KW, Moser C, Eron JJ, Pinilla M, Li JZ, Ritz J, Javan AC, Wohl DA, Daar ES, Currier JS, Smith DM, Hughes[...]

Expert Discussion on Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Challenges and Considerations

Lafayette RA, Charu V, Glassock RJ. Expert Discussion on Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Challenges and Considerations. Adv Ther. 2025 Mar 27. doi: 10.1007/s12325-025-03167-x. Epub ahead[...]

Association of Extracoronary Calcification and Incident Heart Failure in the Multiethnic Study of Atherosclerosis (MESA)

Brar S, Goli R, Barrios JP, Blaha MJ, Kianoush S, Pletcher MJ, Nomura SO, Tsai MY, Duan R, Budoff MJ, Szklo M, Tison GH. Association[...]